Marlex Pharmaceuticals, Inc.
Marlex Pharmaceuticals, Inc. appears in FDA public data with 3 recalls — including 1 Class I (most serious) —, 0 510(k) clearances, 8 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1170-2023, Class II) was initiated on August 25, 2023.
Summary
- Total Recalls
- 3 (1 Class I)
- 510(k) Clearances
- 0
- Inspections
- 8
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1170-2023 | Class II | Digoxin Tablets, USP 0.25mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: Marlex Ph | August 25, 2023 |
| D-1169-2023 | Class I | Digoxin Tablets, USP 0.125mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: Marlex P | August 25, 2023 |
| D-1064-2013 | Class II | Acetaminophen Tablets, 500 mg, 100-count bottles, Distributed by: Marlex Pharmaceuticals, Inc., New | August 8, 2013 |